Elena A. Smolyarchuk - Sechenov Univ, Sechenov First Moscow State Med Univ, Moscow, Russia

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Status and trends of legislative and regulatory regulation of off-label use of drugs: A review

Elena R. Zakharochkina, Vasily V. Ryazhenov,Elena A. Smolyarchuk,Dmitry A. Kudlay, Nаna Yu. Bekhorashvili, Stanislav A. Zaveryachev,Susanna S. Sologova

Терапевтический архивno. 4 (2024): 396-406

引用0浏览0引用

Problems associated with effective pharmacotherapy of the elderly patients (geriatrics): A review

Liudmila A. Korol,Svetlana N. Egorova,Dmitry A. Kudlay,Ivan I. Krasnyuk,Susanna S. Sologova,Viktoria A. Korol,Elena A. Smolyarchuk,Mark A. Mandrik

TERAPEVTICHESKII ARKHIV（2022）

引用1浏览0WOS引用

[Modern extemporaneous formulations in the geriatric care management: current opportunities and future challenges. A review]

L A Korol,S N Egorova,D A Kudlay,I I Krasnyuk,S S Sologova,V A Korol,E A Smolyarchuk, I A Sadkovskii,M A Mandrik

Ter Arkh（2022）

引用1浏览0WOS引用

Development of nitrofuran derivative: composition and technology of effervescent tablets with solid dispersions

A. O. Elagina,A. V. Belyatskaya,I. I. Krasnyuk (Jr.),I. I. Krasnyuk, O. I. Stepanova, T. V. Fateeva,E. A. Smolyarchuk,S. V. Kozin, O. N. Plakhotnaya, O. V. Rаstopchina,J. V. Rau

Pharmacy & Pharmacologyno. 1 (2022): 55-68

引用1浏览0引用

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial

Evgeny Bazdyrev,Maria Panova,Maria Brachs,Elena Smolyarchuk,Daria Tsygankova,Liudmila Gofman,Yana Abdyusheva,Fedor Novikov

J Transl Med（2022）

引用2浏览0WOS引用

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial

Е. Д. Баздырев,Maria V. Panova,Maria Brachs,Е. А. Smolyarchuk,Д. П. Цыганкова,Liudmila Gofman,Yana Abdyusheva,Fedor N. Novikov

Research Square (Research Square) (2022)

引用0浏览0引用

[Comparative clinical study of the pharmacokinetics and bioequivalence of the combined drug Mioreol and the combined use of mono-drugs containing donepezil and memantine]

E A Smolyarchuk, Z N Leykin

Zh Nevrol Psikhiatr Im S S Korsakova（2022）

引用3浏览0WOS引用

Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies

N. V. Lomakin,B. A. Bakirov, G. H. Musaev, V. V. Popov,E. A. Smolyarchuk, Yu. N. Linkova, D. V. Bogdan, A. V. Eremeeva, P. S. Pukhtinskaia, M. A. Morozova, A. V. Zinkina-Orikhan, A. A. Lutckii

Биопрепараты: Профилактика, диагностика, лечениеno. 4 (2022): 446-459

引用0浏览0引用

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study